On March 25, 2024 GC Genome Corporation, a leading diagnostics company, reported that the company will present two poster presentations at the American Association for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting 2024 in San Diego, California, from April 5–10, 2024 (Press release, GC Genome, MAR 25, 2024, View Source [SID1234641419]). During the event, GC Genome will showcase the innovative performance of its liquid biopsy technology for early cancer detection using cfDNA, highlighting its effectiveness across diverse ethnic groups.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Poster Presentation Details:
Title: A deep learning-based multimodal ensemble algorithm for lung cancer early detection with cross-ethnic generalizability
Date and Time: Monday, April 8, 2024 9:00 AM – 12:30 PM PT
Location: Poster Section 40
Poster Board Number: 7
Abstract Number: 2411
Title: Analysis of analytical variables in the cancer detection assay utilizing cfDNA fragmentomics
Date and Time: Tuesday, April 9, 2024 9:00 AM – 12:30 PM PT
Location: Poster Section 40
Poster Board Number: 19
Abstract Number: 5032